top of page

Home

BiotechTV U

Company News

Bright Minds

Tech + Tours

- May 7

SalioGen’s CEO on the company’s ‘Gene Coding’ approach to genetic medicine and an oral presentation today at #ASGCT2024 for its Stargardt disease program

Jason Cole describes how Gene Coding can deliver large sequences to the genome without viral vectors or RNA guides, and describes how these benefits translate to the Stargardt program.

Recent Posts

Biotheryx's CEO on the company's protein degradation platform and CDK4/6 program that is IND cleared and will be entering the clinic

PTC Therapeutics's CEO summarizes a busy year ahead of regulatory decisions and data

Pliant's CEO on targeting integrins to treat fibrotic diseases like IPF and liver disease

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Popular

#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more

#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease

#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more

#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause

#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A

bottom of page